Putting Alzheimer’s on early notice
Australian scientists have presented key findings at an international Alzheimer’s disease conference this week. Their major focus is on early detection and discovering why the disease progresses.
Advance in bowel cancer test research
Australian researchers have developed gene expression biomarkers which can accurately discriminate pre-cancerous and cancerous colorectal growths from non-cancerous controls.
Bioprospecting drives the search for foods with proven health benefits
Food Futures assays used to produce and identify new bioactives present in foods that have proven health benefits.
Current tests screen against risk-factors and biomarkers for coronary heart disease (cholesterol production and uptake, and blood pressure), colorectal cancer and inflammatory diseases. The challenge is identifying novel bioactives that may reduce the incidence of chronic disease.
Developments in microencapsulation technology are creating new applications and opportunities in the food and nutraceutical industries.
Starplus™ starch for healthier bowels
CSIRO’s Starplus™ technology incorporates natural starch from cereals into foods or dietary supplements to improve bowel health and colon function.
Starplus™ is a new technology for delivering optimal concentrations of short chain fatty acids (SCFA), in starch-based products, to the colon. Increasing levels of these acids is likely to have significant preventative and therapeutic effects on gastrointestinal diseases.